関連する実験動画
Updated: Feb 14, 2026

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
12.1K
多発性硬化症における診断画像と治療応答の定量化のためのミエリンの急速な推定
Evangelos Katsarogiannis1, Russell Ouellette2,3, Johan Virhammar1
1Department of Medical Sciences, Neurology, Uppsala University, Uppsala, Sweden.
まとめ
診断イメージング (REMyDI) のためにミエリンを迅速に推定するテクニックは,リトゥキシマブで治療された多発性硬化症患者のミエリン増加を示しており,これはオトログの血液形成性幹細胞移植 (aHSCT) で治療された患者とは違います. このMRI方法は,治療反応のモニタリングに役立ちます.
科学分野:
- 神経画像は,神経イメージングによるものです.
- 放射線学 放射線学
- 多発性硬化症の研究について
背景:
- MRIの進歩により,臨床的な時間枠内で in vivo 骨髄膜のイメージングが可能になりました.
- 多発性硬化症 (MS) は,ミエリン損傷と神経変異を伴う.
- 治療の有効性を評価するには,ミエリンと脳縮のモニタリングが必要です.
研究 の 目的:
- 診断用イメージング (REMyDI) のためのミエリン素の急速評価技術を評価する.
- 多発性硬化症 (pwMS) 患者における縦線ミエリン変化をモニタリングする.
- リトゥキシマブまたはオトログ性造血幹細胞移植 (aHSCT) を受けているpwMSにおける脳縮を評価するために.
主な方法:
- リトゥキシマブ (n=25) またはaHSCT (n=37) で治療された62人のpWMSの遡及的研究.
- 3テスラスキャナーを使用して3つの時間点で取得された脳MRIスキャン.
- REMyDIと脳の体積は,混合効果モデルを使用して分析されました.
主要な成果:
- リトゥキシマブ群は,全脳,皮質,深い灰色の質のミエリンが増加したことを示した.
- 自得性造血幹細胞移植 (aHSCT) グループは,安定したまたは減少するミエリンを示しました.
- 脳パレンキマ分子の減少は,aHSCTグループよりも,リトゥキシマブグループで大きかった.
結論:
- REMyDIは,ミエリンのインビボの縦断的な評価を容易にする.
- REMyDIは,MSモニタリングのための従来の脳体積計を補完しています.
- この技術は,MS患者の治療反応を評価するのに適しています.
さらに関連する動画
関連する概念動画
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
860
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
860
What are Estimates?
8.9K
It isn't easy to measure a parameter such as the mean height or the mean weight of a population. So, we draw samples from the population and calculate the mean height or mean weight of the individuals in the sample. This sample data acts as a representative measure of the population parameter. These sample statistics are known as estimates.
The estimate for the mean of a sample is denoted by ͞x, whereas the mean of the population is designated as μ. Further, parameters such...
The estimate for the mean of a sample is denoted by ͞x, whereas the mean of the population is designated as μ. Further, parameters such...
8.9K
Nervous Tissue: Myelin
6.0K
The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
6.0K
Estimation of k and VD of Aminoglycosides
253
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
253
Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Multiple Allele Traits
38.2K
The Concept of Multiple Allelism
38.2K

